Document Detail


The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women--effects on bleeding patterns, ovarian function and genital shedding of HIV.
MedLine Citation:
PMID:  16880227     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Safe and effective contraceptives are needed for human immunodeficiency virus (HIV)-infected women. The levonorgestrel-releasing intrauterine system (LNG-IUS) is a highly effective contraceptive with additional health benefits. The objective of this study was to evaluate the effects of the LNG-IUS among HIV-infected women. METHODS: Twelve systematically managed HIV-infected women were studied prospectively. Following a 2-month run-in period, the subjects had an LNG-IUS inserted and were followed up for 1 year. Patterns of bleeding, blood haemoglobin and CD4-lymphocyte content, plasma HIV RNA, serum levels of LNG, of estradiol (E(2)) and of ferritin and genital shedding of HIV RNA were monitored. RESULTS: Menstrual bleeding was reduced significantly during the use of the LNG-IUS; this was associated with slight increases in serum haemoglobin and ferritin levels. Serum E(2) concentrations remained in the follicular range in all subjects. Among subjects using antiretroviral medication, the proportion of cervicovaginal lavage specimens with detectable HIV RNA was 10% before and after the insertion of the LNG-IUS. CONCLUSIONS: The effects of the LNG-IUS on bleeding patterns, body iron stores and ovarian function were similar to those seen in healthy women. Genital shedding of HIV RNA was not affected by the LNG-IUS. These data encourage further studies on the effects of the LNG-IUS on reproductive health among HIV-infected women.
Authors:
Oskari Heikinheimo; Päivi Lehtovirta; Jukka Suni; Jorma Paavonen
Related Documents :
20532607 - Substance use in hiv-infected women during pregnancy: self-report versus meconium analy...
16227797 - Eligibility criteria for hiv clinical trials and generalizability of results: the gap b...
7594657 - Cd4+ lymphocytes in perinatal human immunodeficiency virus (hiv) infection: evidence fo...
20592367 - Anal cytology as a screening tool for early detection of anal dysplasia in hiv-infected...
16319687 - Granulocyte transfusion.
24159567 - Epidemiology and surveillance of hepatocellular carcinoma.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-07-31
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  21     ISSN:  0268-1161     ISO Abbreviation:  Hum. Reprod.     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-10-12     Completed Date:  2007-01-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  England    
Other Details:
Languages:  eng     Pagination:  2857-61     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, University of Helsinki, Finland. oskari.heikinheimo@helsinki.fi
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Contraceptive Agents, Female / pharmacology*
Estradiol / blood
Female
HIV / drug effects,  genetics,  isolation & purification*
HIV Infections / physiopathology*
Humans
Levonorgestrel / blood,  pharmacokinetics,  pharmacology*
Menstruation / drug effects*,  physiology
Ovary / drug effects*,  physiopathology
Prospective Studies
Uterus / drug effects*
Viral Load
Virus Shedding / drug effects*
Chemical
Reg. No./Substance:
0/Contraceptive Agents, Female; 50-28-2/Estradiol; 797-63-7/Levonorgestrel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pregnancy outcomes following laparoscopic myomectomy and single-layer myometrial closure.
Next Document:  Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with e...